- Home
- CGEN vs AMPY Comparison
CGEN vs AMPY Comparison
Compare CGEN & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGEN | AMPY |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.1M | 199.8M |
| IPO Year | 2001 | 2011 |
Fundamental Metrics
Financial Performance| Metric | CGEN | AMPY |
|---|---|---|
| Price | $2.48 | $4.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 283.7K | ★ 567.0K |
| Earning Date | 05-18-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 232.26 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $208,637,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $75.09 | $23.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.30 | $3.65 |
| 52 Week High | $3.24 | $6.79 |
Technical Indicators
Market Signals| Indicator | CGEN | AMPY |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 42.65 |
| Support Level | $2.20 | $4.49 |
| Resistance Level | $2.54 | $5.07 |
| Average True Range (ATR) | 0.08 | 0.16 |
| MACD | -0.03 | -0.07 |
| Stochastic Oscillator | 29.31 | 1.74 |
Price Performance
Historical ComparisonAbout CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.